跳至主要内容
临床试验/CTIS2023-503983-17-00
CTIS2023-503983-17-00进行中(未招募)1 期

itroglycerin for Esophageal Food Impaction: A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase 2 Clinical trial - MK2021

ordsjaellands Hospital0 个研究点目标入组 88 人开始时间: 2023年6月7日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 1. Age above 18 years 2.Presentation consistent with EFI for minimum 1 hour 3.Informed consent

排除标准

  • 1.Sharp foreign body in the oesophagus (e.g. chicken bone) 2.Known structural abnormality in the oesophagus 3.Previous esophageal perforation 4.Recent use of phosphodiesterase inhibitors 5.Unresolved severe cardiac disease 6.Circulatory unstable patient 7.Systolic blood pressure < 100 mg 8.Known severe liver disease 9.Pregnancy or Breastfeeding 10.Any other disease/condition judged by the investigator to be grounds for exclusion

研究者

发起方
ordsjaellands Hospital

相似试验